688050-42-2
688050-42-2
Chemical Structure
BCR-ABL-IN-7
- CAS No.: 688050-42-2
- Formula:C19H16FN3O3S
- Molecular Weight:385.41
IUPAC Name: N-(3-carbamoyl-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-5-(4-fluorophenyl)isoxazole-3-carboxamide
InChIKey: ROZYTPXUZIIHHA-UHFFFAOYSA-N
SMILES: O=C(C1=C(NC(C2=NOC(C3=CC=C(F)C=C3)=C2)=O)SC4=C1CCCC4)N
Biological Activity: BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BCR-ABL-IN-7 | 99.66% | BCR-ABL-IN-7 (compound 4) is a WT and T315I mutant ABL kinases inhibitor. BCR-ABL-IN-7 effectively inhibits activities of WT and T315I mutant ABL kinases. BCR-ABL-IN-7 can be used for the research of chronic myeloid leukemia (CML) research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
